QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
In cancer treatment, adjuvant therapy plays a crucial role in reducing the chances of cancer recurrence and, in some cases, improving the odds of a cure. Over the past decade, various studies have examined the use of adjuvant therapy for…
Before the use of prostate biopsy alone to detect prostate cancer, MRI was used as a tool for local staging and as a component of active surveillance (AS). Recently, MRI has been seen as a valuable tool for improving assessments…
Between 2004 and 2020, there was a notable change in how doctors treated prostate cancer in the US, as reported in JAMA Oncology. A research team studied data from the National Cancer Database involving 313,062 patients with localized prostate cancer….
Black men benefit more from prostate cancer screening in general and from personalized biomarkers because they are more likely to harbor genomically-aggressive cancer, even if it appears they have low-risk disease. Prostate cancer mortality rates in Black men are approximately…
In 2016, the Center for Medical Disease reduced the fee for robotic prostatectomy by 33%. The authors hypothesized that adjunct procedures would be added. There is research that the procedure of urethral suspension may accelerate continence recovery, but it is…
A review and analysis examined the use of second-generation antiandrogens (AAs) for treating prostate cancer and their potential cognitive and functional side effects. These AAs, including abiraterone, apalutamide, darolutamide, and enzalutamide, are becoming more frequently used in treatment. The researchers…
As we enter the end-of-year holiday season, I think of the many people with cancer and their families I encounter in my daily activities. I am happy to report that increasingly more patients are having their lives extended and their…
B.J. Rimel, MD is a gynecologic oncologist who by dint of her abiding interest and hard work is the Medical Director of the Cancer Clinical Trials Office at Cedars Sinai Medical Center in Los Angeles, one of the top-ranked hospitals…
The overall cancer mortality rate in the U.S. has decreased continuously since 1991, resulting in an overall drop of 33%: approximately 3.8 million cancer deaths averted. This progress is due to the uptake of screening for breast, colorectal, and prostate cancers….
Every 18 minutes a Black man is diagnosed with prostate cancer – the second leading cause of cancer death in Black men. In 2022, approximately 41,600 Black men were diagnosed that accounted for 37% of all new cancers among Black…
"*" indicates required fields
